Trip6 regulates p27KIP1 to promote tumorigenesis

Molecular and Cellular Biology

Volumn 33, Issue 7, 2013, Pages 1394-1409

  Lin, Victor T G ^a,b   Lin, Vivian Y ^a   Lai, Yun Ju ^b,c   Chen, Chen Shan ^b,d   Liu, Kang ^a   Lin, Weei Chin ^a   Lin, Fang Tsyr ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; LYSOPHOSPHATIDIC ACID; THYROID RECEPTOR INTERACTING PROTEIN 6; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DOSE RESPONSE; FEMALE; GENE SILENCING; GLIOBLASTOMA; HUMAN; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOSOL; FEMALE; GLIOBLASTOMA; GLIOMA; HEK293 CELLS; HUMANS; LIM DOMAIN PROTEINS; LIM-HOMEODOMAIN PROTEINS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION; ZYXIN;

EID: 84875271672     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01149-12     Document Type: Article

References (27)

1. Lin VT, Lin FT. 2011. TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity. Cell. Signal. 23:1691-1697.
2. Lai YJ, Chen CS, Lin WC, Lin FT. 2005. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration. Mol. Cell. Biol. 25:5859 -5868.
3. Lai YJ, Lin VT, Zheng Y, Benveniste EN, Lin FT. 2010. The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration. Mol. Cell. Biol. 30:5582-5596.
4. Xu J, Lai YJ, Lin WC, Lin FT. 2004. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor. J. Biol. Chem. 279:10459 -10468.
5. E S, Lai YJ, Tsukahara R, Chen CS, Fujiwara Y, Yue J, Yu JH, Guo H, Kihara A, Tigyi G, Lin FT. 2009. Lysophosphatidic acid 2 receptormediated supramolecular complex formation regulates its antiapoptotic effect. J. Biol. Chem. 284:14558 -14571.
6. Kassel O, Schneider S, Heilbock C, Litfin M, Gottlicher M, Herrlich P. 2004. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaBregulated promoters. Genes Dev. 18:2518 -2528.
7. Chu IM, Hengst L, Slingerland JM. 2008. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 8:253-267.
8. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. 2004. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 18:862- 876.
9. Wander SA, Zhao D, Slingerland JM. 2011. p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin. Cancer Res. 17:12-18.
10. Vervoorts J, Luscher B. 2008. Post-translational regulation of the tumor suppressor p27(KIP1). Cell. Mol. Life Sci. 65:3255-3264.
11. Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG. 2002. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 21:3390-3401.
12. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M. 1999. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13:1181-1189.
13. Lundgren E, Roos G. 1976. Cell surface changes in HeLa cells as an indication of cell cycle events. Cancer Res. 36:4044-4051.
14. Debnath J, Muthuswamy SK, Brugge JS. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in threedimensional basement membrane cultures. Methods 30:256 -268.
15. Lin FT, Lai YJ, Makarova N, Tigyi G, Lin WC. 2007. The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival. J. Biol. Chem. 282:37759 -37769.
16. Lin FT, Krueger KM, Kendall HE, Daaka Y, Fredericks ZL, Pitcher JA, Lefkowitz RJ. 1997. Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of betaarrestin1. J. Biol. Chem. 272:31051-31057.
17. McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. 2003. Novel p27(kip1) C-terminal scatter domain mediates Racdependent cell migration independent of cell cycle arrest functions. Mol. Cell. Biol. 23:216 -228.
18. Kohn AD, Takeuchi F, Roth RA. 1996. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem. 271:21920 -21926.
19. Wang Y, Gilmore TD. 2003. Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear. Biochim. Biophys. Acta 1593:115- 120.
20. Feuerstein R, Wang X, Song D, Cooke NE, Liebhaber SA. 1994. The LIM/double zinc-finger motif functions as a protein dimerization domain. Proc. Natl. Acad. Sci. U. S. A. 91:10655-10659.
21. Du K, Tsichlis PN. 2005. Regulation of the Akt kinase by interacting proteins. Oncogene 24:7401-7409.
22. Scheid MP, Woodgett JR. 2003. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett. 546:108 -112.
23. Chun J, Kwon T, Lee E, Suh PG, Choi EJ, Sun Kang S. 2002. The Na( )/H( ) exchanger regulatory factor 2 mediates phosphorylation of serum- and glucocorticoid-induced protein kinase 1 by 3-phosphoinositide- dependent protein kinase 1. Biochem. Biophys. Res. Commun. 298: 207-215.
24. Barre B, Perkins ND. 2010. The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis. Mol. Cell 38:524 -538.
25. Chan CH, Lee SW, Wang J, Lin HK. 2010. Regulation of Skp2 expression and activity and its role in cancer progression. ScientificWorldJournal 10:1001-1015.
26. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF. 2004. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 64:6503- 6510.
27. Freeman AK, Morrison DK. 2011. 14-3-3 proteins: diverse functions in cell proliferation and cancer progression. Semin. Cell Dev. Biol. 22:681- 687.